NCT06050915View on ClinicalTrials.gov

A Study of DISC-3405 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

October 3, 2023

Primary Completion Date

July 9, 2024

Study Completion Date

July 9, 2024

Conditions
Healthy Volunteer
Interventions
DRUG

DISC-3405

DISC-3405 is administered as a single dose IV infusion or subcutaneous injection

DRUG

DISC-3405

DISC-3405 is administered in multiple ascending doses as an IV infusion or subcutaneous injection

DRUG

Placebo

Placebo is administered as a single dose IV infusion or subcutaneous injection

DRUG

Placebo

Placebo is administered in multiple ascending doses as an IV infusion or subcutaneous injection

Trial Locations (1)

68502

Celerion, Lincoln

Sponsors

Lead Sponsor

Disc Medicine, Inc
All Listed Sponsors
lead

Disc Medicine, Inc

INDUSTRY

NCT06050915 - A Study of DISC-3405 in Healthy Volunteers | Biotech Hunter | Biotech Hunter